223 related articles for article (PubMed ID: 14637194)
1. Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation.
Alencar JL; Chalupsky K; Sarr M; Schini-Kerth V; Vanin AF; Stoclet JC; Muller B
Biochem Pharmacol; 2003 Dec; 66(12):2365-74. PubMed ID: 14637194
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta.
Muller B; Kleschyov AL; Malblanc S; Stoclet JC
Br J Pharmacol; 1998 Mar; 123(6):1221-9. PubMed ID: 9559908
[TBL] [Abstract][Full Text] [Related]
3. Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone.
Alencar JL; Lobysheva I; Geffard M; Sarr M; Schott C; Schini-Kerth VB; Nepveu F; Stoclet JC; Muller B
Mol Pharmacol; 2003 May; 63(5):1148-58. PubMed ID: 12695543
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
[TBL] [Abstract][Full Text] [Related]
5. Wavelength-dependence of vasodilation and NO release from S-nitrosothiols and dinitrosyl iron complexes by far red/near infrared light.
Keszler A; Lindemer B; Hogg N; Weihrauch D; Lohr NL
Arch Biochem Biophys; 2018 Jul; 649():47-52. PubMed ID: 29752896
[TBL] [Abstract][Full Text] [Related]
6. Vasorelaxing activity of stable powder preparations of dinitrosyl iron complexes with cysteine or glutathione ligands.
Vanin AF; Mokh VP; Serezhenkov VA; Chazov EI
Nitric Oxide; 2007 May; 16(3):322-30. PubMed ID: 17258478
[TBL] [Abstract][Full Text] [Related]
7. Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase.
Keese MA; Böse M; Mülsch A; Schirmer RH; Becker K
Biochem Pharmacol; 1997 Dec; 54(12):1307-13. PubMed ID: 9393673
[TBL] [Abstract][Full Text] [Related]
8. The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione.
Sarr M; Sar FB; Gueye L; Kane MO; Wele A; Diallo AS; Schini-Kerth V; Muller B
Cardiovasc J Afr; 2011; 22(1):7-13. PubMed ID: 21298199
[TBL] [Abstract][Full Text] [Related]
9. Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta.
Muller B; Kleschyov AL; Stoclet JC
Br J Pharmacol; 1996 Nov; 119(6):1281-5. PubMed ID: 8937735
[TBL] [Abstract][Full Text] [Related]
10. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate.
Sarr M; Lobysheva I; Diallo AS; Stoclet JC; Schini-Kerth VB; Muller B
Eur J Pharmacol; 2005 Apr; 513(1-2):119-23. PubMed ID: 15878716
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting hypotensive action of stable preparations of dinitrosyl-iron complexes with thiol-containing ligands in conscious normotensive and hypertensive rats.
Lakomkin VL; Vanin AF; Timoshin AA; Kapelko VI; Chazov EI
Nitric Oxide; 2007 Jun; 16(4):413-8. PubMed ID: 17478115
[TBL] [Abstract][Full Text] [Related]
12. Activation of soluble guanylate cyclase by NO donors--S-nitrosothiols, and dinitrosyl-iron complexes with thiol-containing ligands.
Severina IS; Bussygina OG; Pyatakova NV; Malenkova IV; Vanin AF
Nitric Oxide; 2003 May; 8(3):155-63. PubMed ID: 12826064
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of dinitrosyl iron complexes with reduced glutathione in cardioplegia and reperfusion.
Pisarenko O; Studneva I; Timoshin A; Veselova O
Pflugers Arch; 2019 Apr; 471(4):583-593. PubMed ID: 30613864
[TBL] [Abstract][Full Text] [Related]
14. Dinitrosyl iron complexes with natural thiol-containing ligands in aqueous solutions: Synthesis and some physico-chemical characteristics (A methodological review).
Vanin AF; Borodulin RR; Mikoyan VD
Nitric Oxide; 2017 Jun; 66():1-9. PubMed ID: 28216238
[TBL] [Abstract][Full Text] [Related]
15. Autowave distribution of nitric oxide and its endogenous derivatives in biosystems strongly enhances their biological effects: A working hypothesis.
Vanin AF; Mikoyan VD; Rubtsov NM; Kubrina LN
Nitric Oxide; 2010 Nov; 23(3):175-80. PubMed ID: 20633691
[TBL] [Abstract][Full Text] [Related]
16. Polynuclear water-soluble dinitrosyl iron complexes with cysteine or glutathione ligands: electron paramagnetic resonance and optical studies.
Vanin AF; Poltorakov AP; Mikoyan VD; Kubrina LN; Burbaev DS
Nitric Oxide; 2010 Sep; 23(2):136-49. PubMed ID: 20553936
[TBL] [Abstract][Full Text] [Related]
17. Low molecular mass dinitrosyl nonheme-iron complexes up-regulate noradrenaline release in the rat tail artery.
Kleschyov AL; Hubert G; Munzel T; Stoclet JC; Bucher B
BMC Pharmacol; 2002; 2():3. PubMed ID: 11872148
[TBL] [Abstract][Full Text] [Related]
18. Targeted and persistent effects of NO mediated by S-nitrosation of tissue thiols in arteries with endothelial dysfunction.
Sarr M; Chataigneau M; Etienne-Selloum N; Diallo AS; Schott C; Geffard M; Stoclet JC; Schini-Kerth VB; Muller B
Nitric Oxide; 2007 Aug; 17(1):1-9. PubMed ID: 17566772
[TBL] [Abstract][Full Text] [Related]
19. A simple protocol for the synthesis of dinitrosyl iron complexes with glutathione: EPR, optical, chromatographic and biological characterization of reaction products.
Borodulin RR; Kubrina LN; Shvydkiy VO; Lakomkin VL; Vanin AF
Nitric Oxide; 2013 Nov; 35():110-5. PubMed ID: 24018466
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Escherichia coli SoxRS-regulon by nitric oxide and its physiological donors.
Vasil'eva SV; Stupakova MV; Lobysheva II; Mikoyan VD; Vanin AF
Biochemistry (Mosc); 2001 Sep; 66(9):984-8. PubMed ID: 11703180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
